Form 8-K - Current report:
SEC Accession No. 0001104659-26-022940
Filing Date
2026-03-03
Accepted
2026-03-03 17:10:46
Documents
14
Period of Report
2026-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm267876d1_8k.htm   iXBRL 8-K 28050
2 EXHIBIT 99.1 tm267876d1_ex99-1.htm EX-99.1 244495
6 GRAPHIC tm267876d1_ex99-1img001.jpg GRAPHIC 8053
  Complete submission text file 0001104659-26-022940.txt   474807

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20260303.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20260303_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20260303_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT tm267876d1_8k_htm.xml XML 3193
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 26716307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)